Naser ASLANABADİ, Gholamreza NİAEİ, Amir MONFAREDAN, Farzad JALALİ, Babak NASİRİ, Ali GOLMOHAMMADİ, Fatemeh JAHANJOO

ACE insertion/deletion polymorphism and restenosis events after coronary stent placement in East Azerbaijan Province of Iran

Renin-angiotensin system is thought to play a role in coronary thrombosis and restenosis. Plasma angiotensin I-converting enzyme (ACE) activity is associated with an insertion/deletion polymorphism in the gene coding for ACE. The association among restenosis within coronary stents, the D/I polymorphism is analyzed in the present study. We are selected 50 patients who had undergone successful percutaneous transluminal coronary angioplasty, and angiography during 1 year after it for some reason. The I/D alleles were identified on the basis of polymerase chain reaction (PCR) amplification of the respective fragments from intron 16 of ACE gene. The differences between groups were tested by Chisquare test or Fisher exact test. Result from chi-square test and Fisher exact test shows the lack of differences between two groups with respect to sex, age, diabetes, hypertension, cholesterol, hyperlipidemia, stent type, length of stented segment, stent diameter and target vessel. In the second set of analysis, the relationship between genotypes and the outcome variable was tested. These analyses indicated that there were no statistically significant differences the three groups (?2 (2) = 1.40, p=0 .47). The ACE D/D genotype or D allele does not influence the clinical and angiographic outcome of patients undergoing coronary stent placement. These data suggest that routine determination of the ACE genotype may not help identify patients who are at a higher risk of thrombotic and restenosis events after coronary stent placement.

Tam Metin

Kaynakça

1. Abbasidezfouli A, Akbarian E, Shadmehr MB, Arab M, Javaherzadeh M, Pejhan S, Abbasi-Dezfouli G, Farzanegan R. The etiological factors of recurrence after tracheal resection and reconstruction in post-intubation stenosis. Interact Cardiovasc Thorac Surg. 2009;9(3):446-9.

2. Amant C, Bauters C, Bodart JC, Lablanche JM, Grollier G, Danchin N, Hamon M, Richard F, Helbecque N, McFadden EP, Amouyel P, Bertrand ME. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 1997;96(1):56-60.

3. Ferrari M, Mudra H, Grip L, Voudris V, Schchinger V, de Jaegere P, Rieber J, Hausmann D, Rothman M, Koschyk DH, Figulla HR. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation. Cardiology. 2002;97:29-36.

4. Firouzabadi N, Tajik N, Bahramali E, Bakhshandeh H, Ebrahimi SA, Maadani M, Rasoulian M, Mobasheri T, Shafiei M. Association of angiotensin-converting enzyme polymorphism with coronary artery disease in Iranian patients with unipolar depression. Clin Biochem. 2012;45(16):1347-52.

5. Fukazawa R, Sonobe T, Hamamoto K, Hamaoka K, Sakata K, Asano T, Imai T, Kamisago M, Ohkubo T, Uchikoba Y, Ikegami E, Watanabe M, Ogawa S. Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease. Pediatr Res. 2004;56:597- 601.

6. Guneri S, Baris N, Aytekin D, Akdeniz B, Pekel N, Bozdemir V. The relationship between Angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis. Int Heart J. 2005;46(5):889-97.

7. Hager A, Bildau J, Kreuder J, Kaemmerer H, Hess J. Impact of genomic polymorphism on arterial hypertension after aortic coarctation repair. Int J Cardiol. 2011;151(1):63-8.

8. Heeneman S, Sluimer JC, Daemen MJAP. Angiotensin-Converting Enzyme and Vascular Remodeling. Circulation Research. 2007;101(5):441-54.

9. Kitsios G, Zintzaras E. ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. BMC Medical Genetics. 2009;10:50.

10. Koch W, Mehilli J, von Beckerath N, Bttiger C, Schmig A, Kastrati A. Angiotensin Iconverting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. J Am Coll Cardiol. 2003;41(11):1957-61.

11. Meurice T, Bauters C, HermantX, Codron V, VanBelle E, Mc Fadden EP, Lablanche J, Bertrand ME, Amouyel P. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Lancet. 2001;357(9265):1321-4.

12. Niemiec P, Zak I, Wita K. The D allele of angiotensin I-converting enzyme gene insertion/deletion polymorphism is associated with the severity of atherosclerosis. Genet Test. 2007;11(4):353-9.

13. Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications. Drugs. 2002;62(7):977-93.

14. Oishi Y, Manabe I, Imai Y, Hara K, Horikoshi M, Fujiu K, Tanaka T, Aizawa T, Kadowaki T, Nagai R. Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension. The FASEB Journal. 2010;24(6):1780-8.

15. Okumura K, Sone T, Kondo J, Tsuboi H, Mukawa H, Tsuzuki M, Imai H, Kamiya H, Mabuchi Y, Matsui H, Hayakawa T. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele. Circ J. 2002;66(4):311-6.

16. Ryu SK, Cho EY, Park HY, Im EK, Jang YS, Shin GJ, Shim WH, Cho SY. Reninangiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis. Yonsei Med J. 2002;43(4):461-72.

17. Kane GC, Hambly N, Textor SC, Stanson AW, Garovic VD. Restenosis following percutaneous renal artery revascularization. Nephron Clin Pract. 2007;107(2):c63-9.

18. Ribichini F, Ferrero V, Matullo G, Feola M, Vado A, Camilla T, Guarrera S, Carturan S, Vassanelli C, Uslenghi E, Piazza A. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis. Clin Sci (Lond). 2004;107(4):381-9.

19. Sampietro ML, Trompet S, Verschuren JJW, Talens RP, Deelen J, Heijmans BT, de Winter RJ, Tio RA, Doevendans PA, Ganesh SK, Nabel EG, Westra HJ, Franke L, van den Akker EB, Westendorp RG, Zwinderman AH, Kastrati A, Koch W, Slagboom PE, de Knijff P, Jukema JW. A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention. Hum Mol Genet. 2011;20(23):4748-57.

20. Slowik A, Dziedzic T, Pera J, Wloch D, Kopec G and Szczudlik A. ACE Genotype, Risk and Causal Relationship to Stroke: Implications for Treatment. Curr Treat Options Cardiovasc Med. 2007;9(3):198-204.

21. Zee RY, Fernandez-Ortiz A, Macaya C, Pintor E, Lindpaintner K, Fernandez-Cruz A. Ace D/I polymorphism and incidence of post-PTCA restenosis: a prospective, angiography-based evaluation. Hypertension. 2001;37(3):851-5.